SLS logo

SELLAS Life Sciences Group, Inc. Common Stock


SLS: SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.


Show SLS Financials

Consumer Interest
SEC Filings

Recent trades of SLS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by SLS's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of SLS in WallStreetBets Daily Discussion

SLS News

Recent insights relating to SLS

CNBC Recommendations

Recent picks made for SLS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in SLS

Corporate Flights

Flights by private jets registered to SLS